Form 4 for PRAX Praxis Precision Medicines, Inc.
Accepted 2026-05-19 21:44:39 ET · period of report 2026-05-14 · accession 0001689548-26-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 21:44 | 2026-05-14 | PRAX | Kelly Timothy Edwin | CFO | A - Grant | $167.94 | +121 | 31.2K | +0.4% | +$20.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-14 | A | A | 121 | $167.94 | 31,167 | D | — | — | (F1) These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |